CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphoma.
Parameswaran N, Luo L, Zhang L, Chen J, DiFilippo FP, Androjna C, Fox DA, Ondrejka SL, Hsi ED, Jagadeesh D, Lindner DJ, Lin F.
Parameswaran N, et al. Among authors: zhang l.
Leukemia. 2023 Oct;37(10):2050-2057. doi: 10.1038/s41375-023-01997-8. Epub 2023 Aug 12.
Leukemia. 2023.
PMID: 37573404